Eternygen
Latest round
- Series A
Last raised
- Oct 2020
Total raised
- $14M
Investors
- 4
About Eternygen
Founded in 2012 and based in Berlin, Germany, Eternygen GmbH is a biotech company that focused on the research and development of NaCT inhibitors for the treatment of dietary-related metabolic diseases.
Who invested in Eternygen
4 investors across 3 rounds
See all investors in Eternygen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Eternygen
Who invested in Eternygen?
Eternygen has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Eternygen raised?
Eternygen has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Eternygen last raise money?
Eternygen's most recent round on record is a Series A, in Oct 2020.
What does Eternygen do?
Founded in 2012 and based in Berlin, Germany, Eternygen GmbH is a biotech company that focused on the research and development of NaCT inhibitors for the treatment of dietary-related metabolic diseases.
Where is Eternygen headquartered?
Eternygen is headquartered in Berlin, Germany.
Which VCs invest in companies like Eternygen?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Eternygen's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Eternygen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.